Rns - no massive news6 Dec 2022 09:50
So reading the rns -
Still awaiting funding info from trx - which I previously said should be considered as an aside not the bee all and end all.
301 still progressing
Tnbc - progressing
401 progressing
Bc201 progressing. . .
Have I missed something that Says all of the above have failed?
It's all a work in progress - yes the leasing of a lab is interesting and going forward I am curious how this will be funded BUT correct me if I'm wrong leasing a lab is not buying a lab, so cost per month to rent does not necessarily mean dilution if one of the others starts producing revenue for us.
I do truly believe val sp is being manipulated /possibly shorted while actual news hasn't been given yet.
We are further along I believe than we were but yes disappointing no revenue yet.
C4xd was mentioned earlier with 50 mil mcap but has signed a deal - yes they've signed but upfront payment of 1.5, 16ish on pre clinical the rest 380 mill when goes to market. That is why the map is 50 mill.
We could get there, it will take a bit more time and hopefully ours can be used for various cancers will be more beneficial = higher payment/contract.
I would have preferred no rns to be honest, but imo it was a non news rns as such - everything still ticking along. So I guess it depends on whether shareholders can wait or not and whether they still believe in the products and the company.
I don't have a huge amount of shares, just a few. Yes I'm down on my investment but I still believe in the company.